Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech Gross Profit Margin (Quarterly) : 46.86% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.86% |
| March 31, 2026 | 45.36% |
| December 31, 2025 | 41.04% |
| September 30, 2025 | 46.39% |
| June 30, 2025 | 46.27% |
| March 31, 2025 | 47.85% |
| December 31, 2024 | 42.10% |
| September 30, 2024 | 42.02% |
| June 30, 2024 | 43.36% |
| March 31, 2024 | 46.24% |
| December 31, 2023 | 41.81% |
| September 30, 2023 | 41.31% |
| June 30, 2023 | 48.08% |
| March 31, 2023 | 51.58% |
| December 31, 2022 | 53.16% |
| September 30, 2022 | 52.48% |
| June 30, 2022 | 51.74% |
| March 31, 2022 | 52.70% |
| December 31, 2021 | 52.34% |
| September 30, 2021 | 54.15% |
| June 30, 2021 | 55.30% |
| March 31, 2021 | 53.82% |
| December 31, 2020 | 51.00% |
| September 30, 2020 | 54.06% |
| June 30, 2020 | 52.48% |
| Date | Value |
|---|---|
| March 31, 2020 | 52.76% |
| December 31, 2019 | 52.43% |
| September 30, 2019 | 52.15% |
| June 30, 2019 | 51.47% |
| March 31, 2019 | 51.71% |
| December 31, 2018 | 50.11% |
| September 30, 2018 | 53.12% |
| June 30, 2018 | 52.23% |
| March 31, 2018 | 52.40% |
| December 31, 2017 | 52.35% |
| September 30, 2017 | 51.83% |
| June 30, 2017 | 50.09% |
| March 31, 2017 | 51.08% |
| December 31, 2016 | 48.41% |
| September 30, 2016 | 51.03% |
| June 30, 2016 | 49.92% |
| March 31, 2016 | 51.06% |
| December 31, 2015 | 48.11% |
| September 30, 2015 | 52.03% |
| June 30, 2015 | 52.57% |
| March 31, 2015 | 50.29% |
| December 31, 2014 | 49.18% |
| September 30, 2014 | 50.09% |
| June 30, 2014 | 50.24% |
| March 31, 2014 | 50.58% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 35.34% |
| Sanofi | -- |
| Codexis, Inc. | 68.42% |
| Nicox SA | -- |
| Evotec SE | -1.10% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.14% |
| Return on Assets | 3.65% |
| Return on Invested Capital | 4.36% |
| Profit Margin (Quarterly) | 12.24% |
| Operating Margin (Quarterly) | 20.92% |
| Return on Net Operating Assets | 3.99% |